European Neuropsychopharmacology
Volume 20, Issue 4 , Pages 236-244 , April 2010

The multifaceted effects of oral administration of methylphenidate in juvenile rats: Anxiety, activity, and attention

  • Ning Zhu

      Affiliations

    • Department of Physiology and Pharmacology, State University of New York Downstate Medical Center, Brooklyn, NY, USA
    • Program of Neural and Behavioral Science, State University of New York Downstate Medical Center, Brooklyn, NY, USA
    • ,
  • Jeremy Weedon

      Affiliations

    • Scientific Computing Center, State University of New York Downstate Medical Center, Brooklyn, NY, USA
    • ,
  • Diana L. Dow-Edwards

      Affiliations

    • Department of Physiology and Pharmacology, State University of New York Downstate Medical Center, Brooklyn, NY, USA
    • Corresponding Author InformationCorresponding author. Department of Physiology and Pharmacology, State University of New York Downstate Medical Center, 450 Clarkson Ave, Box 29, Brooklyn, NY, USA, 11209. Tel.: +1 718 270 3987; fax: +1 728 270 2241.

Received 13 October 2009 ,Revised 9 December 2009 ,Accepted 12 December 2009.

References 

  1. Albrechet-Souza L, de Carvalho MC, Franci CR, Bradao ML. Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam. Hormones and Behavior. 2007;53:267–273
  2. Andersen SL, Dumont NL, Teicher MH. Developmental differences in dopamine synthesis inhibition by (+/−)-7-OH-DPAT. Naunyn-Schmiedeberg's Archives of Pharmacology. 1997;356:173–181
  3. Aoyama T, Kotaki H, Iga T. Dose-dependent kinetics of methylphenidate enantiomers after oral administration of racemic methylphenidate to rats. Journal of Pharmacobio-dynamics. 1990;13:647–652
  4. Asan E. The catecholaminergic innervation of the rat amygdala. Advances in Anatomy, Embryology, and Cell Biology. 1998;142:L1–118L
  5. Barrickman LL, Perry PJ, Allen AJ, Kuperman S, Arndt SV, Herrmann KJ, et al. Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 1995;34:649–657
  6. Bethancourt JA, Camarena ZZ, Britton GB. Exposure to oral methylphenidate from adolescence through young adulthood produces transient effects on hippocampal-sensitive memory in rats. Behavioral Brain Research. 2009;202:50–57
  7. Bevins RA, Peterson JL. Individual differences in rats' reactivity to novelty and the unconditioned and conditioned locomotor effects of methamphetamine. Pharmacology, Biochemistry and Behavior. 2004;79:65–74
  8. Bouffard R, Hechtman L, Minde K, Iaboni-Kassab F. The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder. Canadian Journal of Psychiatry. 2003;48:546–554
  9. Britton GB, Bethancourt JA. Characterization of anxiety-related responses in male rats following prolonged exposure to therapeutic doses of oral methylphenidate. Pharmacology Biochemistry and Behavior. 2009;93:451–459
  10. Brown RM, Goldman PS. Catecholamines in neocortex of rhesus monkeys: regional distribution and ontogenetic development. Brain Research. 1977;124:576–580
  11. Bunsey M, Kramer D, Kesler M, Strupp BJ. A vasopressin metabolite increases attentional selectivity. Behavioral Neuroscience. 1990;104:277–287
  12. Challman TD, Lipsky JJ. Methylphenidate: its pharmacology and uses. Mayo Clinic Proceedings. 2000;75:711–721
  13. Chambers RA, Moore J, McEvoy JP, Levin ED. Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia. Neuropsychopharmacology. 1996;15:587–594
  14. Doremus TL, Varlinskaya EI, Spear LP. Factor analysis of elevated plus-maze behavior in adolescent and adult rats. Pharmacology, Biochemistry and Behavior. 2006;83:570–577
  15. Dow-Edwards DL, Weedon JC, Hellmann E. Methylphenidate improves performance on the radial arm maze in periadolescent rats. Neurotoxicology and Teratology. 2008;30:419–427
  16. Eals M, Silverman I. The hunter-gather theory of spatial sex differences: proximate factors mediating the female advantage in recall of object arrays. Ethology and Sociobiology. 1994;15:95–105
  17. Else-Quest N, Hyde J, Goldsmith HH, Van Hulle CA. Gender differences in temperament: a meta-analysis. Psychological Bulletin. 2009;132:33–72
  18. Fernandes C, File SE. The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacology, Biochemistry and Behavior. 1996;54:31–40
  19. Galef Jr., B.G., 1981. The ecology of weaning: parasitism and the achievement of independence by altricial mammals. In: Gubernick, D.J., Klopfer, P.H. (Eds.), Parental care in mammals. Plenum Press, New York, USA, pp. 211–241.
  20. Goldman-Rakic PS, Brown RM. Postnatal development of monoamine content and synthesis in the cerebral cortex of rhesus monkeys. Developmental Brain Research. 1982;4:339–349
  21. Gray JR, Kagan J. The challenge of predicting which children with ADHD will respond positively to methylphenidate. Journal of Applied Developmental Psychology. 2000;21:471–489
  22. Greenhill L, Kollins S, Abikoff H, McCracken J, Riddle M, Swanson J, et al. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry. 2006;45:1284–1293
  23. Horsley RR, Cassaday HJ. Methylphenidate can reduce selectivity in associative learning in an aversive trace conditioning task. Journal of Psychopharmacology. 2007;25:492–500
  24. Klebaur JE, Bevins RA, Segar TM, Bardo MT. Individual differences in behavioral responses to novelty and amphetamine self-administration in male and female rats. Behavioural Pharmacology. 2001;12:267–275
  25. Konkol RJ, Bendeich EG, Breese GR. A biochemical and morphological study of the altered growth pattern of central catecholamine neurons following 6-hydroxydopamine. Brain Research. 1978;140:125–135
  26. Koob GF, Swerdlow NR. The functional output of the mesolimbic dopamine system. Annuals New York Academy of Sciences. 1988;537:216–227
  27. Kuczenski R, Segal DS. Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. Journal of Neuroscience. 2002;22:7264–72718–15
  28. Kudielka BM, Buske-Kirschbaum A, Hellhammer DH, Kirschbaum C. Differential heart rate reactivity and recovery after psychosocial stress (TSST) in healthy children, younger adults, and elderly adults: the impact of age and gender. International Journal of Behavioral Medicine. 2004;11:116–121
  29. Levitt P. Structural and functional maturation of the developing primate brain. The Journal of Pediatrics. 2003;143:S35–S45
  30. Loizou LA, Salt P. Regional changes in monoamines of the rat brain during postnatal development. Brain Research. 1970;20:467–470
  31. Maggiore VD, Ralph MR. The effect of amphetamine on locomotion depends on the motor device utilized: the open field vs. the running wheel. Pharmacology Biochemistry and Behavior. 2000;65:585–590
  32. Markowitz JS, DeVane CL, Pestreich LK, Patrick KS, Muniz R. A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory study. Journal of Child and Adolescent Psychopharmacology. 2006;16:687–698
  33. Mcgivern RF, Huston JP, Byrd D, King T, Siegle GJ, Reilly J. Sex differences in visual recognition memory: support for a sex-related difference in attention in adults and children. Brain and Cognition. 1997;34:323–336
  34. Morris MJ, Dausse JP, Devynck MA, Meyer P. Ontogeny of a1 and a2-adrenoceptors in rat brain. Brain Research. 1980;190:268–271
  35. Olton DS, Samuelson RJ. Remembrance of places. passed: spatial memory in rats. Journal of Experimental Psychology: Animal Behavior Processes. 1976;2:97–116
  36. Olton DS, Collison C, Werz MA. Spatial memory and radial arm maze performance of rats. Learning and Motivation. 1977;8:289–314
  37. Quinn PO. Treating adolescent girls and women with ADHD: gender-specific issues. Journal of Clinical Psychology. 2005;61:579–587
  38. Rapport MD, Quinn SO, DuPaul GJ, Quinn EP, Kelly KL. Attention deficit disorder with hyperactivity and methylphenidate: the effects of dose and mastery level on children's learning performance. Journal of Abnormal Child Psychology. 1989;17:669–689
  39. Robison LM, Sclar DA, Skaer TL, Galin RS. National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990–1995. Clinical Pediatrics. 1999;38:209–217
  40. Rodgers RJ, Cole JC. An ethological analysis of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze. Behavioural Pharmacology. 1993;4:573–580
  41. Rodgers RJ, Haller J, Holmes A, Halasz J, Walton TJ, Brain PF. Corticosterone response to the plus-maze: high correlation with risk assessment in rats and mice. Physiology & Behavior. 1999;68:47–53
  42. Safer DJ, Zito JM, Fine EM. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics. 1996;98:1084–1088
  43. Schildkraut JJ. The catecholamine hypothesis of affective disorders. A review of supporting evidence. International Journal of Psychiatry. 1967;4:203–217
  44. Sonuga-barke EJ, Coghill D, Markowitz JS, Swanson JM, Vandenberghe M, Hatch SJ. Sex differences in the response of children with ADHD to once-daily formulations of methylphenidate. Journal of the American Academy of Child and Adolescent Psychiatry. 2007;46:701–710
  45. Spear L, Shalaby IA, Brick J. Chronic administration of haloperidol during development: behavioral and psychopharmacological effects. Psychopharmacology. 1980;70:47–58
  46. Swanson JM, Volkow ND. Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD. Behavioural Brain Research. 2002;130:73–78
  47. Treit, D. and Fundytus, M. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacology, Biochemistry and Behavior. 1989;31:959–962
  48. Weiss SM, Wadsworth G, Fletcher A, Dourish CT. Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety. Neuroscience and Biobehavioral Reviews. 1998;23:265–271
  49. Yang PB, Amini B, Swann AC, Dafny N. Strain differences in the behavioral responses of male rats to chronically administered methylphenidate. Brain Research. 2003;971:139–152
  50. Yang PB, Swann AC, Dafny N. Acute and chronic methylphenidate dose–response assessment on three adolescent male rat strains. Brain Research Bulletin. 2006;71:301–310
  51. Zhu N, Weedon J, Dow-Edwards DL. Oral methylphenidate improves spatial learning and memory in pre- and periadolescent rats. Behavioral Neuroscience. 2007;121:1272–1279

PII: S0924-977X(09)00281-8

doi: 10.1016/j.euroneuro.2009.12.004

European Neuropsychopharmacology
Volume 20, Issue 4 , Pages 236-244 , April 2010

Article Tools

* Image Usage & Resolution